摘要:
The discovery of a novel series of 2-(4-pyridyl)thienopyridinone GSK-3 beta inhibitors is reported. X-ray crystallography reveals its binding mode and enables rationalization of the SAR. The initial optimization of the template for improved cellular activity and predicted CNS penetration is also presented. (C) 2011 Elsevier Ltd. All rights reserved.